Furthermore, our findings support the notion that terminal arterioles rapidly respond to physiological hyperinsulinemia, and in a time scale that would facilitate both insulin/AA delivery to muscle to support muscle protein anabolic and insulin-mediated actions on glucose uptake processes. The gene discussed is INS; the disease is Hyperinsulinemia.